Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.48 USD | -2.76% | +6.98% | +44.32% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -1.05% | +6.98% | +44.32% | +129.24% | +96.07% | 4.09B |
Technical Rankings Surperformance
- Stock Market
- Equities
- CRNX Stock
- Charts Crinetics Pharmaceuticals, Inc.
- Comparison Chart